Skip navigation

Achieve Contracting Excellence and Compliance with the “Big Four” Federal Programs

November 16-17, 2017
  • Philadelphia, PA

Now in its 9th year, CBI’s Federal Pricing and Reporting conference elevates the conversation and dives deep into the complexity of contracting with the “Big Four” federal programs. In an era of political transformation and industry uncertainty, this highly acclaimed meeting is a mustattend, offering bio/pharma manufacturers best practices and timely updates from government officials and industry counterparts on pricing models and processes for complying with complex rules and regulations. Join the hundreds who have benefited over the years and gain invaluable learnings to stay profitable in this low-margin, highly complex market.

FOUR FEDERAL PROGRAMS.
ONE CHOICE FOR CONTRACTING EXCELLENCE.

  • Gain insight on CMS decision to reverse its long-standing position that products dispensed via the FSS are not eligible for reimbursement by state Medicaid agencies
  • Receive answers to critical questions related to new TAA Non-Compliant Covered Drugs Policy
  • Benchmark with industry counterparts to establish best practices and ensure 340B program compliance
  • Discuss government contracting strategies in specific scenarios designed to minimize loss of profitability and potential revenue leakage
  • Analyze the evolving generic product landscape and discuss best practices to ensure accurate calculation and reporting compliance
  • Gain insight on key Distribution and Pricing Agreement (DAPA) Registration considerations when contracting with the DLA

Previous Attendee Acclaim:

Love the size of the sessions, it lends to knowledge sharing and
a lot of great insightful questions and answers.

Director, Government Pricing and Compliance, Amneal Pharmaceuticals

Very informative, I’m new to this channel and learned a lot.
Thank you!

Associate Director, Policy and Reimbursement Lead, UCB, Inc.

Especially valuable to have VA personnel present and available for discussion. Lots of expertise by speakers and the audience.

Federal Accounts Director, Arbor Pharmaceuticals

The conference gave me valuable information and industry contacts that will be useful in our relations and dealings with the government.

Senior Manager, National Accounts, Sagent Pharmaceuticals

Timely and relevant information sharing from industry experts that has practical application I can take back to the office with me.

Senior Government Pricing Analyst, AstraZeneca

As someone who works with VA, DOD and PHS, this program has consistently given me an update and preparation for the coming year!

Federal Accounts, Teva Pharmaceuticals

It is beneficial to attend to hear the important factors of
government pricing reporting.

Manager, Government Pricing, Merck

Need to keep having this meeting!

Senior Director, Pricing and Contracting, Santarus Inc.

Having VA, NAC and OIG speakers at this conference is
very helpful and informative. Great choices.

Sr. Analyst Government Pricing, Daiichi Sankyo

November 16-17, 2017 The Wyndham Philadelphia, PA

Government Pricing Series banner